ParkinsonFranceV1, PubMed, Checkpoint, bibRecord, 001043

[Alpha-2 adrenergic receptors and Parkinson's disease].

Identifieur interne : 001043 ( PubMed/Checkpoint ); précédent : 001042; suivant : 001044

[Alpha-2 adrenergic receptors and Parkinson's disease].

Auteurs : Anne-Marie Bonnet [France]

Source :

Presse medicale (Paris, France : 1983) [ 0755-4982 ] ; 2002.

RBID : pubmed:12192732

English descriptors

KwdEn :
- Adrenergic alpha-2 Receptor Antagonists, Antiparkinson Agents (pharmacology), Antiparkinson Agents (therapeutic use), Humans, Levodopa (pharmacology), Levodopa (physiology), Levodopa (therapeutic use), Neuroprotective Agents (pharmacology), Neuroprotective Agents (therapeutic use), Norepinephrine (deficiency), Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Piribedil (pharmacology), Piribedil (therapeutic use), Receptors, Adrenergic, alpha-2 (drug effects), Receptors, Adrenergic, alpha-2 (physiology).
MESH :
- chemical , deficiency : Norepinephrine.
- chemical , drug effects : Receptors, Adrenergic, alpha-2.
- chemical , pharmacology : Antiparkinson Agents, Levodopa, Neuroprotective Agents, Piribedil.
- chemical , physiology : Levodopa, Receptors, Adrenergic, alpha-2.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa, Neuroprotective Agents, Piribedil.
- chemical : Adrenergic alpha-2 Receptor Antagonists.
- drug therapy : Parkinson Disease.
- physiopathology : Parkinson Disease.
- Humans.

PubMed: 12192732

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001176
to stream PubMed, to step Curation: 001135

Links to Exploration step

pubmed:12192732

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Alpha-2 adrenergic receptors and Parkinson's disease].</title>
<author><name sortKey="Bonnet, Anne Marie" sort="Bonnet, Anne Marie" uniqKey="Bonnet A" first="Anne-Marie" last="Bonnet">Anne-Marie Bonnet</name>
<affiliation wicri:level="3"><nlm:affiliation>Fédération de Neurologie, Hôpital de La Pitié-Salpetrière, 47-83 Boulevard de l'Hôpital, 75013 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Fédération de Neurologie, Hôpital de La Pitié-Salpetrière, 47-83 Boulevard de l'Hôpital, 75013 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12192732</idno>
<idno type="pmid">12192732</idno>
<idno type="wicri:Area/PubMed/Corpus">001176</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001176</idno>
<idno type="wicri:Area/PubMed/Curation">001135</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001135</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001135</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001135</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Alpha-2 adrenergic receptors and Parkinson's disease].</title>
<author><name sortKey="Bonnet, Anne Marie" sort="Bonnet, Anne Marie" uniqKey="Bonnet A" first="Anne-Marie" last="Bonnet">Anne-Marie Bonnet</name>
<affiliation wicri:level="3"><nlm:affiliation>Fédération de Neurologie, Hôpital de La Pitié-Salpetrière, 47-83 Boulevard de l'Hôpital, 75013 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Fédération de Neurologie, Hôpital de La Pitié-Salpetrière, 47-83 Boulevard de l'Hôpital, 75013 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Presse medicale (Paris, France : 1983)</title>
<idno type="ISSN">0755-4982</idno>
<imprint><date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenergic alpha-2 Receptor Antagonists</term>
<term>Antiparkinson Agents (pharmacology)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Humans</term>
<term>Levodopa (pharmacology)</term>
<term>Levodopa (physiology)</term>
<term>Levodopa (therapeutic use)</term>
<term>Neuroprotective Agents (pharmacology)</term>
<term>Neuroprotective Agents (therapeutic use)</term>
<term>Norepinephrine (deficiency)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Piribedil (pharmacology)</term>
<term>Piribedil (therapeutic use)</term>
<term>Receptors, Adrenergic, alpha-2 (drug effects)</term>
<term>Receptors, Adrenergic, alpha-2 (physiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="deficiency" xml:lang="en"><term>Norepinephrine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Receptors, Adrenergic, alpha-2</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
<term>Neuroprotective Agents</term>
<term>Piribedil</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Levodopa</term>
<term>Receptors, Adrenergic, alpha-2</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
<term>Neuroprotective Agents</term>
<term>Piribedil</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Adrenergic alpha-2 Receptor Antagonists</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12192732</PMID>
<DateCreated><Year>2002</Year>
<Month>08</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted><Year>2002</Year>
<Month>09</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>12</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0755-4982</ISSN>
<JournalIssue CitedMedium="Print"><Volume>31</Volume>
<Issue>25</Issue>
<PubDate><Year>2002</Year>
<Month>Jul</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>Presse medicale (Paris, France : 1983)</Title>
<ISOAbbreviation>Presse Med</ISOAbbreviation>
</Journal>
<ArticleTitle>[Alpha-2 adrenergic receptors and Parkinson's disease].</ArticleTitle>
<Pagination><MedlinePgn>1193-5</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bonnet</LastName>
<ForeName>Anne-Marie</ForeName>
<Initials>AM</Initials>
<AffiliationInfo><Affiliation>Fédération de Neurologie, Hôpital de La Pitié-Salpetrière, 47-83 Boulevard de l'Hôpital, 75013 Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Récepteurs alpha 2-adrénergiques et maladie de Parkinson.</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Presse Med</MedlineTA>
<NlmUniqueID>8302490</NlmUniqueID>
<ISSNLinking>0755-4982</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D058669">Adrenergic alpha-2 Receptor Antagonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018341">Receptors, Adrenergic, alpha-2</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>46627O600J</RegistryNumber>
<NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>DO22K1PRDJ</RegistryNumber>
<NameOfSubstance UI="D010891">Piribedil</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber>
<NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D058669" MajorTopicYN="Y">Adrenergic alpha-2 Receptor Antagonists</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000978" MajorTopicYN="N">Antiparkinson Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName>
<QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010891" MajorTopicYN="N">Piribedil</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018341" MajorTopicYN="N">Receptors, Adrenergic, alpha-2</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>28</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year>
<Month>8</Month>
<Day>24</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2002</Year>
<Month>9</Month>
<Day>7</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2002</Year>
<Month>8</Month>
<Day>24</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">12192732</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
</settlement>
</list>
<tree><country name="France"><region name="Île-de-France"><name sortKey="Bonnet, Anne Marie" sort="Bonnet, Anne Marie" uniqKey="Bonnet A" first="Anne-Marie" last="Bonnet">Anne-Marie Bonnet</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001043 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001043 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:12192732
   |texte=   [Alpha-2 adrenergic receptors and Parkinson's disease].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:12192732" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

[Alpha-2 adrenergic receptors and Parkinson's disease].

[Alpha-2 adrenergic receptors and Parkinson's disease].

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki